An AI-generated drug showed early signs of potentially slowing aging, according to a new study out today in Nature Biotechnology, possibly taking the first small step towards using AI to cure all the diseases tech companies companies keep talking about. The new study centers on rentosertib, a drug from Insilico Medicine, an AI drug discovery and development company. From the onset, Insilico said it created rentosertib with the aim of both treating patients